- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Current Price: $8.10
The company’s price target has been increased to $15 by Brean Capital due to positive Ph III Zerenex data. The stock has a Buy rating.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.